Header Logo

Connection

GLENN CUNNINGHAM to Middle Aged

Back to Details
This is a "connection" page, showing publications GLENN CUNNINGHAM has written about Middle Aged.
GLENN CUNNINGHAM
Connection Strength
0.319
Middle Aged
  1. EFFICACY AND SAFETY OF A NEW TOPICAL TESTOSTERONE REPLACEMENT GEL THERAPY FOR THE TREATMENT OF MALE HYPOGONADISM. Endocr Pract. 2017 May; 23(5):557-565.
    View in: PubMed
    Score: 0.034
  2. Effects of glycemia on immediate complications following CABG. Endocr Pract. 2013 Nov-Dec; 19(6):928-36.
    View in: PubMed
    Score: 0.027
  3. Andropause or male menopause? Rationale for testosterone replacement therapy in older men with low testosterone levels. Endocr Pract. 2013 Sep-Oct; 19(5):847-52.
    View in: PubMed
    Score: 0.027
  4. Hypogonadism in male patients with cancer. Cancer. 2006 Jun 15; 106(12):2583-91.
    View in: PubMed
    Score: 0.016
  5. Andropause: is androgen replacement therapy indicated for the aging male? Annu Rev Med. 2005; 56:117-37.
    View in: PubMed
    Score: 0.015
  6. Gonadal and erectile dysfunction in diabetics. Med Clin North Am. 2004 Jul; 88(4):933-45, xi.
    View in: PubMed
    Score: 0.014
  7. Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism. J Clin Endocrinol Metab. 2024 Jan 18; 109(2):569-580.
    View in: PubMed
    Score: 0.014
  8. Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial. JAMA Netw Open. 2023 12 01; 6(12):e2348692.
    View in: PubMed
    Score: 0.014
  9. Familial aggregation of prostate cancer in African-Americans and white Americans. Prostate. 2003 Sep 01; 56(4):256-62.
    View in: PubMed
    Score: 0.014
  10. Hypogonadism and diabetes. Int J Impot Res. 2003 Aug; 15 Suppl 4:S14-20.
    View in: PubMed
    Score: 0.013
  11. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023 Jul 13; 389(2):107-117.
    View in: PubMed
    Score: 0.013
  12. Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan. J Androl. 2003 May-Jun; 24(3):299-311.
    View in: PubMed
    Score: 0.013
  13. Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE study. Am Heart J. 2022 03; 245:41-50.
    View in: PubMed
    Score: 0.012
  14. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018 05 01; 103(5):1715-1744.
    View in: PubMed
    Score: 0.009
  15. Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME). J Sex Med. 2017 09; 14(9):1104-1115.
    View in: PubMed
    Score: 0.009
  16. Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME). Int J Clin Pract. 2016 Oct; 70(10):843-852.
    View in: PubMed
    Score: 0.008
  17. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men. BJU Int. 2017 Feb; 119(2):216-224.
    View in: PubMed
    Score: 0.008
  18. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF TESTOSTERONE AND CARDIOVASCULAR RISK. Endocr Pract. 2015 Sep; 21(9):1066-73.
    View in: PubMed
    Score: 0.008
  19. The assessment of vascular risk in men with erectile dysfunction: the role of the cardiologist and general physician. Int J Clin Pract. 2013 Nov; 67(11):1163-72.
    View in: PubMed
    Score: 0.007
  20. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010 Jun; 95(6):2536-59.
    View in: PubMed
    Score: 0.005
  21. Testosterone replacement therapy and sleep-related erections in hypogonadal men. J Clin Endocrinol Metab. 1990 Mar; 70(3):792-7.
    View in: PubMed
    Score: 0.005
  22. Testosterone replacement with transdermal therapeutic systems. Physiological serum testosterone and elevated dihydrotestosterone levels. JAMA. 1989 May 05; 261(17):2525-30.
    View in: PubMed
    Score: 0.005
  23. Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J Clin Endocrinol Metab. 2005 May; 90(5):2920-6.
    View in: PubMed
    Score: 0.004
  24. New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men. J Clin Endocrinol Metab. 2004 Aug; 89(8):3821-9.
    View in: PubMed
    Score: 0.004
  25. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. J Clin Endocrinol Metab. 2004 May; 89(5):2179-84.
    View in: PubMed
    Score: 0.004
  26. Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men. Clin Endocrinol (Oxf). 2001 Jun; 54(6):739-50.
    View in: PubMed
    Score: 0.003
  27. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab. 2000 Dec; 85(12):4500-10.
    View in: PubMed
    Score: 0.003
  28. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab. 2000 Aug; 85(8):2839-53.
    View in: PubMed
    Score: 0.003
  29. An FSH and prolactin-secreting pituitary tumor: pituitary dynamics and testicular histology. J Clin Endocrinol Metab. 1977 Feb; 44(2):248-53.
    View in: PubMed
    Score: 0.002
  30. Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM. Diabetes Care. 1995 Jun; 18(6):843-51.
    View in: PubMed
    Score: 0.002
  31. The use of insulin dynamics in the evaluation of streptozotocin therapy of malignant insulinomas. J Clin Endocrinol Metab. 1971 Sep; 33(3):530-6.
    View in: PubMed
    Score: 0.001
  32. Plasma growth hormone during sleep in young and aged men. J Gerontol. 1983 Sep; 38(5):519-24.
    View in: PubMed
    Score: 0.001
  33. Isolated deficiency of adrenocorticotropin (ACTH) and lipotropins (LPHs). J Clin Endocrinol Metab. 1978 Jul; 47(1):84-90.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.